Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Fibrinogen antagonists from Glaxo Wellcome

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Novel rapamycin derivatives reported by Novartis

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Biorex discloses antiischemic agents

Feb. 20, 1997

Subtype-selective 5-HT1 antagonists from Pierre Fabre

Feb. 20, 1997

PFT inhibitors described by Warner-Lambert

Feb. 20, 1997

Zambon discloses ACE/NEP inhibitors

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...